Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JAMP METHOTREXATE DIN 02562979

Status: Approved
Holder: JAMP PHARMA CORPORATION
Molecule: METHOTREXATE (METHOTREXATE DISODIUM)

Health Canada record

Active ingredient(s)METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01BA01 METHOTREXATE
Original market date
Current status date28-Nov-2025
SourceHealth Canada DPD

Establishment licence of the holder

Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing METHOTREXATE (METHOTREXATE DISODIUM)

DINProductCompanyFormStrengthStatus
02509067ACH-METHOTREXATEACCORD HEALTHCARE INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed
02182963APO-METHOTREXATEAPOTEX INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed
02524023AURO-METHOTREXATEAURO PHARMA INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed
02546515EUGIA-METHOTREXATEEUGIA PHARMA INC.TabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGApproved
02534916M-METHOTREXATEMANTRA PHARMA INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed
02562839METHOTREXATE TABLETS, USPPFIZER CANADA ULCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 10 MGApproved
02170698PMS-METHOTREXATEPHARMASCIENCE INCTabletMETHOTREXATE (METHOTREXATE DISODIUM) 2.5 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
364502025-11-28Abbreviated New Drug Submission (ANDS)
Request a quote for JAMP METHOTREXATE

How to read a Canadian DIN record